Financials
Financial year 2025
Worth noting
- A loss two years in a row.
- Little cash and receivables against the short-term debts.
Gross margin
€ -45,230
▲ 41% vs 2024
Profit
Caution€ -1.6 million
▼ 70% vs 2024
Debts
High€ 8.9 million
▲ 79% vs 2024
ConvEyXo from Charleroi, company number BE0725874259, closed financial year 2025 with a result of € -1.6 million after tax. For that financial year ConvEyXo recorded a gross margin of € -45,230 and equity of € 1.4 million. Compared with financial year 2024, the result moved from € -946,720 to € -1.6 million. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.
What happened at ConvEyXo?
What happened at ConvEyXo in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Michael Scholl stepped down as director. NBB
- TONGLET CONSULT SRL stepped down as director. NBB
- JPP CONSULTING SRL stepped down as director. NBB
- FONDS DE CAPITAL A RISQUE 2020 SA stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 1.6 million. Source: NBB ↗
- Michael Scholl became a director. NBB
- TONGLET CONSULT SRL became a director. NBB
- JPP CONSULTING SRL became a director. NBB
In short
From € 817,799 loss in 2021 to € 1.6 million loss in 2025.
Paid € 2,169 in corporate taxes since 2021.
A new publication or filing at ConvEyXo? We notify you, reason included.
Follow ConvEyXoNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
Director · represented by Jean-Paul PRIEELS
Also active at: CURAVAC EUROPE, PDC line Pharma, XomeXBio +1 more
since 2022 · until 2028
Michael Scholl
Director
since 2023 · until 2029
Director · represented by Frédéric Tonglet
Also active at: XomeXBio, Exo-Harvest
since 2023 · until 2029
FONDS DE CAPITAL A RISQUE 2020 SA
Director · represented by Helena Posioz
Also active at: MintT, LYS MEDICAL, APAXEN +5 more
since 2022 · until 2028
Establishments
Establishment units
Physical locations of this company
Rue Clément Ader 10
6041 Charleroi
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 31 companies are registered at this address.
Brussels South Charleroi BioPark Dev
€ 80,186 gross margin · 2025
ImmunXperts
€ 393,338 gross margin · 2024
LYS MEDICAL same network
€ -309,203 gross margin · 2025
SPECTRALYS BIOTECH
€ 143,689 gross margin · 2025
ProtonW.be
€ -7,643 gross margin · 2025
+26 more
Details
- Company number
- 0725.874.259
- VAT number
- BE 0725.874.259
- Registered office
- Rue Clément Ader 10, 6041 Charleroi
- Names & denominations
- ConvEyXo
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 30 April 2019
- Peppol
- Active · Active since 20 Nov 2020
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Speur- en ontwikkelingswerk op het gebied van de maatschappij- en geesteswetenschappen
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied